Clinical Trial

Effectiveness of 3D-printed Patient-specific Resorbable Scaffolds for Maxillary Bone Regeneration

Study acronym: OSTEOPRINT
Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated January 15, 2025 (before its estimated March 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to test the bone formation capacity of a 3D printed scaffold with a plastic material called Polycaprolactone (PCL), compared to the use of synthetic bone grafts, for bone formation in the maxilla or mandible of elderly patients in the city of Valdivia between the years 2023-2024. The main beneficiaries will be patients, users of the public or private health system, who require bone regeneration. The intermediate beneficiaries are the health team: doctors specializing in surgery and orthopedics, dentists, maxillofacial surgeons, dedicated to bone reconstruction and regeneration. The innovation of this new material is based on the provision of a biocompatible plastic, easy to handle, for domestic 3D printing of bone matrices that can be grafted in areas requiring bone regeneration.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-12.
Trial Details
NCT Number NCT06773923
Lead Sponsor Universidad Austral de Chile
Conditions Bone Loss, Jaw, Edentulous, Edentulous Mouth, Jaw Fractures, Bone Loss, Age Related
Enrollment 10 participants
Start Date 2024-07-01
Primary Completion 2025-03-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-15